According to a new report, published by KBV research, The Global Urinalysis Test Market size is expected to reach $4.8 billion by 2029, rising at a market growth of 6.3% CAGR during the forecast period.
The Instruments segment is showcasing a CAGR of 9.5% during (2023 - 2029). This is because a urine analyzer is used in clinical settings for automatic urine testing. The devices can detect and quantify many analytes, including bilirubin, protein, glucose, and red blood cells. A form of reflectance photometer with a processing speed of several hundred strips per hour, urine strip readers are a common feature of many versions. Utilizing unique Digital Flow Morphology technology lessens the requirement for human microscopic analysis.
The Disease Screening segment acquired maximum revenue share in the Global Urinalysis Test Market by Application in 2022 thereby, achieving a market value of $3.5 billion by 2029. This is due to the assistance in the early diagnosis and screening of several disorders, including diabetes, kidney disease, and urinary tract infections (UTIs). A frequent diagnostic procedure to check for conditions such as urinary tract infections, renal problems, diabetes, and liver problems is urinalysis.
The Hospitals & Clinics segment has shown a high growth rate of 6.7% during (2023 - 2029). This is due to the widespread use of urinalysis products in clinics and hospitals. Also, because urinalysis offers quick and largely reliable results, it is a useful tool for healthcare professionals using diagnostic laboratories to identify and treat various illnesses, which has increased the need for urinalysis equipment in these facilities. In addition, the large patient population in a hospital that needs care for diabetes and other chronic diseases fuels the segment's expansion.
The North America market dominated the Global Urinalysis Test Market by Region in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $1.7 billion by 2029. The Europe market is exhibiting a CAGR of 5.7% during (2023 - 2029). Additionally, The Asia Pacific market would display a CAGR of 7.3% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/urinalysis-test-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Cardinal Health, Inc., Siemens Healthineers AG (Siemens AG), ACON Laboratories, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Arkray, Inc., Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Becton, Dickinson and Company.
By Product
By Application
By End User
By Geography
Companies Profiled
Unique Offerings 
